US20110313348A1 - Novel drug delivery technology - Google Patents

Novel drug delivery technology Download PDF

Info

Publication number
US20110313348A1
US20110313348A1 US13/217,672 US201113217672A US2011313348A1 US 20110313348 A1 US20110313348 A1 US 20110313348A1 US 201113217672 A US201113217672 A US 201113217672A US 2011313348 A1 US2011313348 A1 US 2011313348A1
Authority
US
United States
Prior art keywords
drug
device
delivery device
drug delivery
packaged
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US13/217,672
Other versions
US8574188B2 (en
Inventor
David Stuart Potter
Charles David Ogilvy Potter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enesi Pharma Ltd
Original Assignee
Glide Pharmaceutical Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB0121914.6 priority Critical
Priority to GBUK0121914.6 priority
Priority to GB0121914A priority patent/GB2379390B/en
Priority to GBUK0218126.1 priority
Priority to GB0218126A priority patent/GB2391480B/en
Priority to GB0218126.1 priority
Priority to US10/238,415 priority patent/US7615234B2/en
Priority to US11/633,804 priority patent/US8088406B2/en
Priority to US13/217,672 priority patent/US8574188B2/en
Application filed by Glide Pharmaceutical Technologies Ltd filed Critical Glide Pharmaceutical Technologies Ltd
Publication of US20110313348A1 publication Critical patent/US20110313348A1/en
Assigned to CARETEK MEDICAL LIMITED reassignment CARETEK MEDICAL LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: POTTER, CHARLES DAVID OGILVY, POTTER, DAVID STUART
Assigned to GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED reassignment GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: CARETEK MEDICAL LIMITED
Application granted granted Critical
Publication of US8574188B2 publication Critical patent/US8574188B2/en
Assigned to Enesi Pharma Limited reassignment Enesi Pharma Limited ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links